Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
By J. Gilleron, W. Querbes, Anja Zeigerer, A. Borodovsky, Giovanni Marsico, Undine Schubert, K. Manygoats, S. Seifert, Cordula Andree, M. Stöter and 10 more. Nature Biotechnology, 2013
1,456 citations recorded by the source corpus.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/9ff23fddbc3af9e218dc679dcf57bdbf7b5f84ed
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- M. Hope
- Arnab Rudra
- Daniel G. Anderson
- R. Juliano
- Lei Miao
- Morgan L. Maeder
- Piotr S. Kowalski
- P. Cullis
Citations in the corpus
- Lipid Nanoparticle Systems for Enabling Gene Therapies. (2017, background): “The potential for improvement is clear in that <5% of endocytosed LNP siRNA is actually released into the cell cytosol.(40) Up to 60% is recycled to the extracellular medium,(41) and much of the remaining endocytosed LNP siRNA proceeds to other non-productive endpoints such as degradation in lysosom”
- Efficient Delivery of Genome-Editing Proteins In Vitro and In Vivo (2014, background): “We note, however, that the majority of this protein is likely sequestered within endosomes and may not be immediately available to effect genome modification.(4,9)”
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery. (2019, positive): “22,23 Once inside the cell, LNPs are routed into early endosomes, followed by late endosomes, and fi nally the lysosomes where the mRNA contents are enzymatically degraded.”
- The delivery of therapeutic oligonucleotides (2016, background): “(181) found that LNPs were initially taken up by clathrinmediated endocytosis but further accumulation involved macropinocytosis.”